Keyphrases
Direct-to-consumer Advertising
100%
Proton Pump Inhibitors
100%
Product Switching
50%
Omeprazole
33%
Co-payment
33%
Switcher
33%
Lansoprazole
33%
United States
16%
Tolerability
16%
Drug Use
16%
Disease Diagnosis
16%
Population Density
16%
Diagnostic Procedures
16%
Insurance
16%
Drug Costs
16%
U.S. Census
16%
Health Plans
16%
Commercially Available
16%
Comorbidity
16%
Prescription Drugs
16%
Retrospective Cohort Study
16%
Employer-sponsored Health Insurance
16%
Treatment Costs
16%
Single Product
16%
Well-distributed
16%
Medical Costs
16%
Working Adults
16%
Insurance Coverage
16%
Marketing Area
16%
Administrative Dataset
16%
Diagnostic Costs
16%
Advertising Expenditure
16%
Product Variables
16%
Patient Cost-sharing
16%
Therapeutic Switching
16%
Patient Diagnosis
16%
Medicine and Dentistry
Consumer
100%
Proton-Pump Inhibitor
100%
Diagnosis
50%
Health Care Cost
33%
Lansoprazole
33%
Omeprazole
33%
Cost Sharing
16%
Drug Use
16%
Retrospective Cohort Study
16%
Patient Characteristics
16%
Prescription Drug
16%
Population Density
16%
Comorbidity
16%
Nursing and Health Professions
Consumer
100%
Proton Pump Inhibitor
100%
Diagnosis
50%
Omeprazole
33%
Lansoprazole
33%
Drug Use
16%
Drug Cost
16%
Independent Practice Association
16%
Cohort Analysis
16%
Prescription Drug
16%
Comorbidity
16%
Pharmacology, Toxicology and Pharmaceutical Science
Proton Pump Inhibitor
100%
Omeprazole
40%
Lansoprazole
40%
Tolerability
20%
Cohort Study
20%
Prescription Drug
20%
Disease
20%
Comorbidity
20%
Economics, Econometrics and Finance
Direct Marketing
100%
Health Insurance
16%
Deductible
16%